Cargando…
RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
This review summarizes the history, function, application, and achievement of the RheumCloud App as a novel smartphone application. This App reflects the development of the Chinese Rheumatism Data Center (CRDC), which provides not only a technical platform for the database and registry of rheumatic...
Autores principales: | Huang, Can, Zhao, Jiuliang, Tian, Xinping, Wang, Qian, Xu, Dong, Li, Mengtao, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984926/ https://www.ncbi.nlm.nih.gov/pubmed/36879841 http://dx.doi.org/10.2478/rir-2022-0033 |
Ejemplares similares
-
The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022) -
Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022) -
Early Initiation of Anticoagulation Improves the Long-Term Prognosis in Patients With Antiphospholipid Syndrome Associated Portal Vein Thrombosis
por: You, Hanxiao, et al.
Publicado: (2021) -
Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
por: Zhou, Yangzhong, et al.
Publicado: (2023) -
Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)